Report ID: SQMIG35A2495
Report ID:
SQMIG35A2495 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
64 |
Figures:
75
Notably, North America commands a prominent position in the market due to its substantial patient base and favorable reimbursement policies. The region secured a substantial market share of 45.67% in 2022. This is underpinned by Canada's noteworthy contribution, where over 3 million individuals are grappling with diabetes, with the prevalence rate growing by approximately 3.3% annually, accounting for the elderly population. Furthermore, escalating healthcare expenditures by consumers in North America are propelling market growth.
Anticipated to exhibit robust growth during the forecast period, the Asia Pacific region is poised to be a key growth driver. This growth is fueled by the surge in disease prevalence and heightened awareness campaigns promoting effective insulin use and storage. Government initiatives and educational programs further contribute to propelling the market's expansion. Remarkably, Asia hosts nearly 60% of the global diabetes population. With rapid economic development and urbanization, the region is witnessing a significant increase in working-age individuals affected by diabetes, consequently driving demand for insulin storage devices.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35A2495